Allianz Asset Management GmbH - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 72 filers reported holding CYTOSORBENTS CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2019$661,000
-69.7%
131,472
-60.2%
0.00%
-50.0%
Q2 2019$2,182,000
-13.4%
330,086
-0.8%
0.00%0.0%
Q1 2019$2,520,000
-7.4%
332,870
-1.1%
0.00%
-33.3%
Q4 2018$2,720,000
-39.8%
336,632
-3.9%
0.00%
-25.0%
Q3 2018$4,517,000
+53.8%
350,178
+35.9%
0.00%
+33.3%
Q2 2018$2,937,000257,6700.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders